ACADIA Pharmaceuticals Inc. v. Aurobindo Pharma Limited et al
ACADIA Pharmaceuticals Inc. |
Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. |
1:2022cv01387 |
October 21, 2022 |
US District Court for the District of Delaware |
Gregory B Williams |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. ยง 271 Patent Infringement |
None |
Docket Report
This docket was last retrieved on December 13, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 9 NOTICE requesting Clerk to remove Aubrey J. Morin as co-counsel. Reason for request: No longer with the firm of Saul Ewing LLP. (Streifthau-Livizos, Michelle) |
SO ORDERED, re #8 MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Chad J. Peterman, Scott F. Peachman, Rebecca A. Hilgar and Felix A. Eyzaguirre filed by ACADIA Pharmaceuticals Inc. Signed by Judge Gregory B. Williams on 12/5/22. (ntl) |
Filing 8 MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Chad J. Peterman, Scott F. Peachman, Rebecca A. Hilgar and Felix A. Eyzaguirre - filed by ACADIA Pharmaceuticals Inc.. (Streifthau-Livizos, Michelle) |
Filing 7 WAIVER OF SERVICE returned executed by ACADIA Pharmaceuticals Inc.: For Aurobindo Pharma USA, Inc. waiver sent on 11/3/2022, answer due 1/3/2023. (Streifthau-Livizos, Michelle) |
Filing 6 WAIVER OF SERVICE returned executed by ACADIA Pharmaceuticals Inc.: For Aurobindo Pharma Limited waiver sent on 11/3/2022, answer due 1/3/2023. (Streifthau-Livizos, Michelle) |
Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. Associated Cases: 1:22-cv-01386-UNA, 1:22-cv-01387-UNA, 1:22-cv-01388-UNA(nms) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by ACADIA Pharmaceuticals Inc.. (Streifthau-Livizos, Michelle) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,452,271. (mkr) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: See Attached. (mkr) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) |
Filing 1 COMPLAINT for PATENT INFRINGEMENT filed against Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. (Filing fee $402, receipt number ADEDC-3988503.) - filed by ACADIA Pharmaceuticals Inc. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(mkr) |
No Summons Issued. (mkr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.